Variable | For death | For progression-free survival | ||||
---|---|---|---|---|---|---|
Hazard Ratio | 95% confidence interval | p | Hazard Ratio | 95% confidence interval | p | |
Age < 58.00 years (VS. ≥ 58 years) | 1.046 | 0.701 to 1.562 | 0.825 | 1.036 | 0654 to 1.642 | 0.880 |
Gender Male (VS. Female) | 0.713 | 0.474 to1.073 | 0.105 | 0.733 | 0.409 to 1.278 | 0.165 |
Clinical stage IV + III (VS. II +I) | 0.988 | 0.500 to1.952 | 0.972 | 1.355 | 0.558 to 3.121 | 0.476 |
Tumor invasion T 4 + T 3 (VS. T 2 + T 1 ) | 2.175 | 0.896 to 5.278 | 0.086 | 1.432 | 0.547 to 3.747 | 0.465 |
Nodal stage N 3 + N 2 (VS. N 1 + N 0 ) | 1.056 | 0.681 to1.638 | 0.808 | 1.243 | 0.751 to 2.059 | 0.397 |
Differentiation Low (VS. High) | 0.765 | 0.470 to1.243 | 0.279 | 0.810 | 0.478 to1.375 | 0.463 |
14-3-3σ Positive (VS. Negative) | 5.161 | 2.990 to 8.909 | 0.000 | 4.416 | 2.482 to 7.856 | 0.000 |